Trump Hints at Potential Changes to Mifepristone Access During Press Conference
- Former President Donald Trump may revoke access to mifepristone, a drug used in medication abortions.
- The announcement was made during a news conference at his Mar-a-Lago resort.
- The potential ban on the abortion pill raises concerns among women's rights advocates.
During a press conference at his Mar-a-Lago resort, former President Donald Trump suggested he might consider revoking access to mifepristone, a key drug used in medication abortions. Responding to a question from NBC News, Trump stated, "You could do things that... would supplement — absolutely," indicating a willingness to explore options regarding abortion access. This marks a notable shift from his previous stance in June, where he asserted, "I will not block it." Karoline Leavitt, the Trump campaign's national press secretary, attempted to clarify his position, emphasizing that Trump supports state rights in making abortion decisions. She reiterated that the Supreme Court's ruling on the matter is settled, despite Trump's ambiguous comments. The potential revocation of mifepristone aligns with the policy proposals outlined in Project 2025, a comprehensive plan developed by conservative groups, including the Heritage Foundation, for a future GOP administration. Trump also faced questions about his voting intentions regarding Florida's upcoming ballot initiative aimed at expanding abortion access. While he refrained from disclosing his vote, he hinted at a forthcoming announcement, downplaying the significance of abortion as a current issue. In response, Julie Chavez Rodriguez, campaign manager for Harris-Walz, criticized Trump's remarks, highlighting the adverse effects of his policies on women's health care and the ongoing struggles faced by those seeking reproductive services. The Supreme Court's recent ruling preserved nationwide access to abortion pills, with RNC spokeswoman Danielle Alvarez noting the unanimous decision.